summary
Introduced
02/27/2025
02/27/2025
In Committee
03/27/2025
03/27/2025
Crossed Over
Passed
Dead
05/16/2025
05/16/2025
Introduced Session
2025 Regular Session
Bill Summary
Modifies provisions relating to ketamine
AI Summary
This bill modifies Missouri's controlled substance laws, specifically focusing on ketamine administration for mental health purposes. The bill adds three key provisions regarding ketamine: first, physicians cannot delegate the authority to order ketamine hydrochloride for mental health purposes to anyone else under their Drug Enforcement Administration registration; second, if a physician delegates ketamine administration to a certified registered nurse anesthetist, the physician must be on-site and immediately available to supervise and respond to patient needs during treatment; and third, intravenous ketamine treatment for mental health cannot be administered without a documented diagnosis and treatment plan from a licensed physician. The bill also maintains existing regulations about controlled substance prescriptions for various medical professionals, such as advanced practice registered nurses and veterinarians, and includes restrictions on self-prescribing and personal use of controlled substances. These new provisions aim to ensure stringent oversight and patient safety when ketamine is used for mental health treatment.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Second Read and Referred S Families, Seniors and Health Committee (on 03/27/2025)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Document Type | Source Location |
---|---|
State Bill Page | https://www.senate.mo.gov/25info/BTS_Web/Bill.aspx?SessionType=R&BillID=6632538 |
BillText | https://www.senate.mo.gov/25info/pdf-bill/intro/SB830.pdf |
Analysis - Summary: Introduced | https://www.senate.mo.gov/25info/BTS_Web/Summary.aspx?SessionType=R&SummaryID=1725603&BillID=6632538 |
Loading...